Regulatory Affairs opportunities

Emerging opportunities across regulatory affairs, tracked by Korim Index.

• The FDA's evidence-grade AI demand creates a regulatory audit constraint
• Private equity's healthcare pivot creates a regulatory bottleneck
• The AI-mediated interaction control shortage forming under financial services regulation
• The expertise wedge forming under the drug-device CRL scrutiny
• US banking regulation creates a GenAI model risk gap
• The medical comms compliance bottleneck forming under MHRA AI enforcement
• Pharma Regulatory Submissions Moving Toward AI Governance And Audit Trails As Gold Standard